In a recently released analyst research update, Canaccord Genuity Equity Research Analyst Matt Bottomley reiterated his Speculative Buy rating on shares of Sunniva Inc. (CSE:SNN) (OTC:SNNVF) with a sky-high price target.
This analyst update comes just days after it was announced that the personal health data of approximately 34,000 medical cannabis patients was compromised in a data breach of an electronic medical record system used by Sunniva Inc. and its Natural Health Services Ltd. subsidiary.
Matt Bottomley’s price target of $10.00 CAD per share implies a potential upside of approximately 92.31% based on the last traded price of $5.20 CAD on the CSE.
Be sure to subscribe to updates here so you never miss an important development.
Get Real-Time Updates from MJobserver.com